NYSE:ABT

Abbott Laboratories Stock Insider Trading

Healthcare > Medical - Devices

Buy ABT

*Your capital is at risk

$105.70

+0.0750 (+0.0710%)

At Close: Jul 31, 2026

Abbott Laboratories Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 90.32. In total, the insiders bought 1.74M and sold 79.17K ABT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	90.32
● Buy	1.74M shares
● Sell	79.17K shares
78% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Feb 24, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 90.32. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 31, 2025 Buy	Stock Equivalent Units A-Award	Roman Michael F Director	Director	301 Value: $37.7K
Dec 31, 2025 Buy	Stock Equivalent Units A-Award	Stratton John G Director	Director	313 Value: $39.2K
Dec 31, 2025 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	62 Value: $8K
Dec 12, 2025 Buy	Common Stock J-Other	Ahuja Nita Insider	Other	0 Value: $0
Dec 12, 2025 Buy	Option (right to buy)	Scoggins Christopher J Executive Vice President	CEO / President	45 730 Value: $6.19M
Dec 12, 2025 Buy	Option (right to buy)	Scoggins Christopher J Executive Vice President	CEO / President	31 721 Value: $3.71M
Dec 12, 2025 Buy	Option (right to buy)	Scoggins Christopher J Executive Vice President	CEO / President	37 483 Value: $3.98M
Dec 12, 2025 Buy	Option (right to buy)	Scoggins Christopher J Executive Vice President	CEO / President	48 852 Value: $5.74M
Dec 12, 2025 Buy	Option (right to buy)	Scoggins Christopher J Executive Vice President	CEO / President	63 991 Value: $7.94M
Dec 12, 2025 Buy	Option (right to buy)	Scoggins Christopher J Executive Vice President	CEO / President	68 578 Value: $6.02M
Dec 12, 2025 Buy	Option (right to buy)	Scoggins Christopher J Executive Vice President	CEO / President	43 388 Value: $3.47M
Dec 12, 2025 Buy	Option (right to buy)	Scoggins Christopher J Executive Vice President	CEO / President	51 557 Value: $3.91M
Dec 12, 2025 Buy	Common shares without par value	Scoggins Christopher J Executive Vice President	CEO / President	0 Value: $0
Dec 11, 2025 Sell	Common shares without par value G-Gift	Salvadori Daniel Gesua Sive EVP And Group President	CEO / President	1 536 Value: $189.4K
Nov 25, 2025 Sell	Common shares without par value S-Sale	Shroff Eric Senior Vice President	CEO / President	1 586 Value: $203.0K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Stratton John G Director	Director	293 Value: $39.2K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Roman Michael F Director	Director	281 Value: $37.6K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Gonzalez Patricia Paola Director	Director	246 Value: $32.9K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	58 Value: $8K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	58 Value: $8K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Gonzalez Patricia Paola Director	Director	246 Value: $32.9K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Roman Michael F Director	Director	281 Value: $37.6K
Sep 30, 2025 Buy	Stock Equivalent Units A-Award	Stratton John G Director	Director	293 Value: $39.2K
Sep 01, 2025 Sell	Common shares without par value F-InKind	Mccoy John A. Jr. Vice President And Controller	CEO / President	79 Value: $10.5K
Sep 01, 2025 Sell	Common shares without par value F-InKind	Boudreau Philip P EVP And CFO	C-Suite Officer	387 Value: $51.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABBOTT LABORATORIES

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepa...

Read Full Profile Here